Get started by consulting a JUVÉDERM® XC doctor near you.
Individual results may vary.
JUVÉDERM® XC smoothes away facial wrinkles* - instantly.
See more before and after pictures...
Now you can get something extra with your JUVÉDERM® XC treatment. Extra value. Ongoing benefits.Only with JUVÉDERM® XC.
* In the United States, JUVÉDERM® is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds or "parentheses lines").
‡ This includes all JUVÉDERM® injectable gel formulations. Most subjects acquired optimal correction at initial treatment.
† This includes all JUVÉDERM® injectable gel formulations. Most subjects acquired optimal correction at initial treatment.
Ω Compared to the non-lidocaine JUVÉDERM® formulation.
* In the United States, JUVÉDERM® is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
Δ When diagnosed as moderate to severe facial wrinkles and folds.
Β January 2009 through May 2010.
1. Grimes PH, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8:162-168. Please see JUVÉDERM® Ultra, JUVÉDERM® Ultra Plus, JUVÉDERM® Ultra XC, and JUVÉDERM® Ultra Plus XC Patient Safety Information for more information.
2. Data on file, Allergan, Inc., May 2010; US Facial Injectables Market Share Report; GuidePoint Filler Share Tracker.
1.Grimes PH, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8:162-168. Please see JUVÉDERM® Ultra, JUVÉDERM® Ultra Plus,
JUVÉDERM® Ultra XC, and JUVÉDERM® Ultra Plus XC Patient Safety Information for more information.
*In the United States, JUVÉDERM® is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
◊January through October 2009.
1. Data on file, Allergan, Inc., November 2009; US Facial Injectables Market Share Report; GuidePoint Filler Share Tracker.
JUVÉDERM® is part of the Allergan portfolio of products and this is the JUVÉDERM® website. For information on BOTOX ® Cosmetic, visit www.botoxcosmetic.com.
JUVÉDERM® injectable gel (including JUVÉDERM® Ultra, JUVÉDERM® Ultra Plus, JUVÉDERM® Ultra XC, and JUVÉDERM® Ultra Plus XC) is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
Treatment side effects are usually mild to moderate, lasting 7 days or less, and include temporary injection-site reactions such as redness, pain, firmness, swelling, and bumps. JUVÉDERM® is not for people with severe allergies.
For more information, please click on the About Safety link at www.juvederm.com or call the Allergan Product Support line at 1-877-345-5372. JUVÉDERM® injectable gel is available by prescription only.
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines
between the eyebrows (glabellar lines) in people 18 to 65 years of age for a short period of time (temporary).
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have
any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:
The dose of BOTOX® Cosmetic is not the same as, or comparable to, another botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines.
Serious and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy welts, wheezing, asthma symptoms,
or dizziness or feeling faint. Tell your doctor or get medical help right away if you are wheezing or have asthma symptoms, or if you
become dizzy or faint.
Do not take BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients);
had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the
planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), myasthenia
gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including severe dysphagia (difficulty swallowing)
and respiratory compromise (difficulty breathing) from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have surgery; had surgery on your face; weakness of forehead
muscles, such as trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to breast-feed (it is not known
if BOTOX® Cosmetic passes into breast milk).
Human albumin and spread of viral diseases. BOTOX® Cosmetic contains albumin, a protein component of human blood. The potential risk of
spreading viral diseases [eg Creutzfeldt-Jakob Disease (CJD)] via human serum albumin is extremely rare. No cases of viral diseases
or CJD have ever been reported in association with human serum albumin.
Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal products.
Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told
your doctor that you have received BOTOX® Cosmetic in the past.
Especially tell your doctor if you: have received any other botulinum toxin product in the last 4 months; have received injections
of botulinum toxin, such as Myobloc®, Dysport®, or Xeomin® in the past
(be sure your doctor knows exactly which product you received);
have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; or take a sleep medicine.
Other side effects of BOTOX® Cosmetic include: dry mouth, discomfort or pain at the injection site, tiredness, headache,
neck pain, and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids,
and dry eyes.
For more information refer to the Medication Guide or talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.
The NATRELLE® Collection of Breast Implants is indicated for females for breast augmentation and breast reconstruction.
©2012 Allergan, Inc. ® and ™ marks owned by Allergan, Inc. JUVÉDERM® mark owned by Allergan Industrie SAS.
Dysport® is a registered trademark of Ipsen Biopharm Limited
Myobloc® is a registered trademark of Solstice Neurosciences, Inc
Xeomin is a registered trademark of Merz Pharma GmbH & Co. KGaA.